Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Leukemias or Myelodysplastic Syndromes

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access